Pulsed Inhaled Nitric Oxide for the Treatment of Patients With Mild or Moderate COVID-19
view all Clinical Trials
The search for novel therapies to address the ongoing coronavirus (COVID-19) pandemic is ongoing. No proven therapies have been identified to prevent progression of the virus. Preliminary data suggest that inhaled nitric oxide (iNO) could have benefit in preventing viral progression and reducing reliance on supplemental oxygen and ventilator support.
Expanded access allows for iNO to be delivered via the portable INOpulse delivery system for the treatment of COVID-19.
For more information about this trial or to inquire about eligibility, email email@example.com or call 215-707-1359.